170 related articles for article (PubMed ID: 12220625)
21. Coexistence of alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells.
Perrem K; Colgin LM; Neumann AA; Yeager TR; Reddel RR
Mol Cell Biol; 2001 Jun; 21(12):3862-75. PubMed ID: 11359895
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of tankyrase 1 in human gastric cancer cells enhances telomere shortening by telomerase inhibitors.
Zhang H; Yang MH; Zhao JJ; Chen L; Yu ST; Tang XD; Fang DC; Yang SM
Oncol Rep; 2010 Oct; 24(4):1059-65. PubMed ID: 20811689
[TBL] [Abstract][Full Text] [Related]
23. Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines.
Strahl C; Blackburn EH
Mol Cell Biol; 1996 Jan; 16(1):53-65. PubMed ID: 8524329
[TBL] [Abstract][Full Text] [Related]
24. Telomerase inhibitors and 'T-oligo' as cancer therapeutics: contrasting molecular mechanisms of cytotoxicity.
Rankin AM; Faller DV; Spanjaard RA
Anticancer Drugs; 2008 Apr; 19(4):329-38. PubMed ID: 18454043
[TBL] [Abstract][Full Text] [Related]
25. Immortalized cells with no detectable telomerase activity. A review.
Reddel RR; Bryan TM; Murnane JP
Biochemistry (Mosc); 1997 Nov; 62(11):1254-62. PubMed ID: 9467849
[TBL] [Abstract][Full Text] [Related]
26. Telomeres and telomerases as drug targets.
Rezler EM; Bearss DJ; Hurley LH
Curr Opin Pharmacol; 2002 Aug; 2(4):415-23. PubMed ID: 12127874
[TBL] [Abstract][Full Text] [Related]
27. [Effect of tankyrase antisense oligonucleotide combined human telomerase reverse transcriptase antisense oligonucleotide on telomere dynamics in human lung adenocarcinoma A549 cells].
Lu HD; Huang T; Shen WZ; Zhen Y; Kong QZ
Ai Zheng; 2007 Nov; 26(11):1164-9. PubMed ID: 17991312
[TBL] [Abstract][Full Text] [Related]
28. A novel telomere elongation in an adriamycin-resistant stomach cancer cell line with decreased telomerase activity.
Kim JH; Lee GE; Kim JC; Lee JH; Chung IK
Mol Cells; 2002 Apr; 13(2):228-36. PubMed ID: 12018844
[TBL] [Abstract][Full Text] [Related]
29. Telomerase inhibition, telomere shortening, cell growth suppression and induction of apoptosis by telomestatin in childhood neuroblastoma cells.
Binz N; Shalaby T; Rivera P; Shin-ya K; Grotzer MA
Eur J Cancer; 2005 Dec; 41(18):2873-81. PubMed ID: 16253503
[TBL] [Abstract][Full Text] [Related]
30. Alternative lengthening of telomeres in hTERT-inhibited laryngeal cancer cells.
Chen W; Xiao BK; Liu JP; Chen SM; Tao ZZ
Cancer Sci; 2010 Aug; 101(8):1769-76. PubMed ID: 20545697
[TBL] [Abstract][Full Text] [Related]
31. Influence of 3'-azido-2',3'-dideoxyguanosine treatment on telomere length in human telomerase-immortalized human fibroblast cells.
Kurashina Y; Liu X; Kato C; Inoue N; Saneyoshi M; Yamaguchi T
Nucleic Acids Symp Ser (Oxf); 2009; (53):249-50. PubMed ID: 19749354
[TBL] [Abstract][Full Text] [Related]
32. Telomerase inhibition using azidothymidine in the HT-29 colon cancer cell line.
Brown T; Sigurdson E; Rogatko A; Broccoli D
Ann Surg Oncol; 2003 Oct; 10(8):910-5. PubMed ID: 14527910
[TBL] [Abstract][Full Text] [Related]
33. Alternative lengthening of telomeres in the human adrenocortical carcinoma cell line H295R.
Fujiwara M; Kamma H; Wu W; Yano Y; Homma S; Satoh H
Int J Oncol; 2006 Aug; 29(2):445-51. PubMed ID: 16820888
[TBL] [Abstract][Full Text] [Related]
34. Screening of telomerase inhibitors.
Kleideiter E; Piotrowska K; Klotz U
Methods Mol Biol; 2007; 405():167-80. PubMed ID: 18369824
[TBL] [Abstract][Full Text] [Related]
35. Potent inhibition of telomerase by small-molecule pentacyclic acridines capable of interacting with G-quadruplexes.
Gowan SM; Heald R; Stevens MF; Kelland LR
Mol Pharmacol; 2001 Nov; 60(5):981-8. PubMed ID: 11641426
[TBL] [Abstract][Full Text] [Related]
36. Tankyrase 1 as a target for telomere-directed molecular cancer therapeutics.
Seimiya H; Muramatsu Y; Ohishi T; Tsuruo T
Cancer Cell; 2005 Jan; 7(1):25-37. PubMed ID: 15652747
[TBL] [Abstract][Full Text] [Related]
37. Telomere maintenance in Wilms tumors: first evidence for the presence of alternative lengthening of telomeres mechanism.
Venturini L; Daidone MG; Motta R; Collini P; Spreafico F; Terenziani M; Piva L; Radice P; Perotti D; Zaffaroni N
Genes Chromosomes Cancer; 2011 Oct; 50(10):823-9. PubMed ID: 21769957
[TBL] [Abstract][Full Text] [Related]
38. Repression of an alternative mechanism for lengthening of telomeres in somatic cell hybrids.
Perrem K; Bryan TM; Englezou A; Hackl T; Moy EL; Reddel RR
Oncogene; 1999 Jun; 18(22):3383-90. PubMed ID: 10362359
[TBL] [Abstract][Full Text] [Related]
39. Alternative lengthening of telomeres can be maintained by preferential elongation of lagging strands.
Min J; Wright WE; Shay JW
Nucleic Acids Res; 2017 Mar; 45(5):2615-2628. PubMed ID: 28082393
[TBL] [Abstract][Full Text] [Related]
40. Telomerase reverse transcriptase (hTERT) mRNA and telomerase RNA (hTR) as targets for downregulation of telomerase activity.
Natarajan S; Chen Z; Wancewicz EV; Monia BP; Corey DR
Oligonucleotides; 2004; 14(4):263-73. PubMed ID: 15665594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
